2019
DOI: 10.1097/qad.0000000000002199
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of increased HIV testing among MSM in The Netherlands

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 35 publications
0
10
0
1
Order By: Relevance
“…While we examine the impact of increased testing frequency among key populations as a whole, previous research has described the benefits of targeting high-risk groups within key populations. [40] Individuals who engage in risky behaviors, such as those with more sexual partners, practicing unprotected sex, or needle sharing may benefit from additional testing or linkage to HIV prevention such as PrEP. Further research is needed on the optimal testing intervals for higher-risk groups of key populations.…”
Section: Discussionmentioning
confidence: 99%
“…While we examine the impact of increased testing frequency among key populations as a whole, previous research has described the benefits of targeting high-risk groups within key populations. [40] Individuals who engage in risky behaviors, such as those with more sexual partners, practicing unprotected sex, or needle sharing may benefit from additional testing or linkage to HIV prevention such as PrEP. Further research is needed on the optimal testing intervals for higher-risk groups of key populations.…”
Section: Discussionmentioning
confidence: 99%
“…We used a stochastic agent-based transmission model and an economic model that we have developed earlier to study the impact and cost-effectiveness of HIV prevention measures [10][11][12]. The transmission model describes infection with HIVor Neisseria gonorrhoeae (NG) via sexual relationships of MSM.…”
Section: The Transmission and The Economic Modelmentioning
confidence: 99%
“…These numbers were used as input in the economic model to calculate the costs of HIV and NG testing and treatment, PrEP monitoring and medication. Values and sources of the parameters of the economic model are shown in Tables S4-S7, Supplemental Digital Content, http:// links.lww.com/QAD/C114 and in [11][12]. Health effects were expressed in quality-adjusted life-years (QALY).…”
Section: The Transmission and The Economic Modelmentioning
confidence: 99%
“…In the past two decades, three studies estimated the chlamydia population prevalence in the Netherlands. This was 2.0% (95% CI 1.7 to 2.3) in 2002/2003 among 16-29 year old's, 2.7% between 2008-2011 among 16-29 year old's and 2.8% (95% CI 1.5% to 5.2%) in 2016/2017 among 18-34 year old's, all within each other's 95% confidence interval (82,84,85). At the Sexual Health Centers (SHC), detailed information of clients who are tested for chlamydia about characteristics and sexual risk behavior is collected.…”
Section: Epidemiology Of Chlamydiamentioning
confidence: 83%
“…Upper-middle and lower income countries had the highest chlamydia prevalence's. In the Netherlands, there are an estimated 60,000 new chlamydia infections each year (82,83). In the past two decades, three studies estimated the chlamydia population prevalence in the Netherlands.…”
Section: Epidemiology Of Chlamydiamentioning
confidence: 99%